(3.237.20.246) 您好!臺灣時間:2021/04/15 10:23
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果

詳目顯示:::

我願授權國圖
: 
twitterline
研究生:胡廷威
研究生(外文):Tin-Weiu Hu
論文名稱:探討抗血栓蛇毒蛋白Rhodostomin對於單核性白血球之結合及其效應
論文名稱(外文):Effect of a disintegrin, Rhodostomin, on the binding and function of monocytes
指導教授:黃德富
學位類別:碩士
校院名稱:國立臺灣大學
系所名稱:藥理學研究所
學門:醫藥衛生學門
學類:藥學學類
論文種類:學術論文
論文出版年:2005
畢業學年度:93
語文別:中文
論文頁數:82
中文關鍵詞:抗血栓蛇毒蛋白單核性白血球
外文關鍵詞:disintegrinRhodostominmonocytes
相關次數:
  • 被引用被引用:0
  • 點閱點閱:314
  • 評分評分:系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:0
蛇毒成份中,有一類低分子量,結構中均富含cysteine且含特定氨基酸序列RGD (Arg-Gly-Asp) loop, 並以適當的雙硫結構構成一個具彈性的髮夾環,進而凸顯RGD序列,使其能跟黏著分子(integrin)產生緊密的結合,此類蛇毒蛋白總稱為抗黏著蛇毒蛋白disintegrins.此類蛇毒蛋白能藉由它們對未受活化或受到刺激劑活化之血小板上的αllb β3 integrin的高度親合力而去拮抗αllbβ3 integrin之作用,進而抑制血小板的凝集作用。 Rhodostomin是一種由馬來亞腹蛇(Calloselasma rhodostoma) 蛇毒中純化而來的一種中鏈的disintegrin,主要作用可以選擇性地去阻斷αllbβ3及 αvβ3這兩個黏著分子,具有抗血栓和血管新生之活性;但對於白血球方面的研究仍在起步階段,因此我們想利用rhodostomin去研究disintegrin對於人類單核性白血球功能性的影響。將rhodostomin接合上FITC來作為探針工具,並利用流式細胞儀分析人類單核性白血球與它的反應。我們發現rhodostomin除了能與單核性白血球產生結合外,也發現它們之間的結合具有呈濃度相關的性質併呈現飽和的趨勢。在活化劑PMA的存在下,rhodostomin跟單核性白血球之結合現象會明顯增加。我們也證實rhodostomin不會被單核性白血球所吞噬,這說明了rhodostomin與單核性白血球之結合應具有特異性。EDTA並無法抑制rhodostomin與單核性白血球的結合。CD11b/CD18(Mac-1)的天然結合物-纖維蛋白原(2 mg/ml),其能部份抑制rhodostomin與被PMA活化之單核性白血球的結合(35%的抑制);GRGDS (300 μM)也有同樣的抑制作用。我們同時也利用附著試驗觀察rhodostomin跟單核性白血球之間的附著現象,發現它們之間有濃度相關性的附著現象;LDL-receptor-related protein是一個多功能的受體,它可調控白血球上 β2 integrin 的表現和 β2 integrin附著到內皮細胞的現象,在共軛焦顯微鏡也發現它與β2 integrin也有colocalization的現象,因此我們接著去探討rhodostomin與LRP的關係。我們利用流式細胞儀分析,可發現rhodostomin會抑制α4,αM,αX以及LRP單源抗體結合至受刺激劑刺激的人類單核性白血球上;也發現單核球上確實有大量LRP的表現,而LRP單源抗體明顯競爭性地抑制β2黏著分子在單核球上的表現。且rhodostomin不但會競爭性地抑制LRP單源抗體結合上單核球,且隨著rhodostomin濃度的增加,抑制的程度也有增加的傾向。另外在附著試驗我們也發現α4,αM,αX以及LRP單源抗體皆可抑制rhodostomin跟單核性白血球之間的附著現象

Rhodostomin 能部份抑制經由Mac-1受體附著到固定相纖維蛋白原上的單核性白血球,也能抑制經由受α4β1體附著到固定相fibronectin上的單核性白血球,也間接地印證在流式細胞儀發現rhodostomin會作用在α4,αM,αX integrin的現象。另外我們也發現rhodostomin可以濃度相關性地去抑制經由LPS刺激下單核球上組織因子的表現及促凝血活性。

綜合上述結果可知rhodostomin可與單核性白血球結合,可能經由和單核性白血球上的 β2 integrin或是LRP作用,進而影響單核性白血球的功能,例如跟基質蛋白的附著、組織因子的表現及活性。因此, rhodostomin可能具有抗發炎療效的潛力,研究disintegrin或類似蛇毒蛋白成份在抗發炎的活體效應應是另一重要探討之方向。
Disintegrin , a group of low molecular weight , cysteine-rich snake venom polypeptides which contain an Arg-Gly-Asp (RGD) loop maintained by specific disulfide bridge. They exhibit high binding affinities to both resting and activated αIIbβ3 on platelets in a divalent cation-dependent manner , interfering with fibrinogen binding to αIIbβ3 integrin and consequently blocking platelet aggregation. Rhodostomin , a medium chain disintegrin isolated from the venom of Calloselasma rhodostoma , blocks platelet aggregation and angiogenesis through selective binding to platelet αIIbβ3 and endothelial αVβ3 , respectively. The research regarding the effect of rhodostomin on leukocytes is just in the beginning , so we studied the effect of rhodostomin on the function of monocytes in this study. By flow cytometric analysis of human monocytic THP-1 cells , we found that rhodostomin interacted with monocytes, and the binding was dose-dependent and saturable. EDTA did not inhibit the binding of rhodostomin. In addition, bound rhodostomin was not internalized. Soluble fibrinogen (2mg/ml), a natured ligand of Mac-1 (CD11b/CD18), and the peptides, GRGDS(300 μM), inhibited the binding of the rhodostomin to PMA-activated THP-1 cells, indicating the RGD motif in rhodostomin is essential for its binding activity. We also found that THP-1 cells bound to immobilized rhodostomin in a dose-dependent manner. PMA also increased their binding to immobilized rhodostomin.
β-integrin clustering on activation is a key event in leukocyte adhesion to the endothelium during the inflammatory response. LDL-receptor-related protein (LRP), a multifunctional receptor, can regulate the expression of β2 integrin, and affects the adhesion between monocytes and endothelial cells. Confocal microscopy also revealed that endogenously expressed LRP and αLβ2 colocalized in monocytes. In this study, using flow cytometry, we found that rhodostomin significantly inhibited the binding of mAb raised against α4、αM、αX and LRP to PMA-activated THP-1 cells. In addition , we found that LRP was highly expressed on THP-1 cells and LRP mAb inhibited the binding of LRP mAb to PMA-activated THP-1 cell, and rhodostomin inhibited the binding of LRP mAb to PMA-activated THP-1 cells in a dose-dependent manner. Rhodostomin blocked the Mac-1 and VLA-4-dependent adhesion of activated THP-1 cells to immobilized fibrinogen and fibronectin, respectively. On the other hand, we also found that rhodostomin blocked the expression and procoagulant activity of tissue factor on THP-1 cells stimulated by LPS in a dose-dependent manner.
Take together ,these data suggest that rhodostomin may affect the adhesion and tissue factor expression of THP-1 cells through its binding to LRP or α4、αM、αX integrin subunit. Whether rhodostomin and its derivatives exhibit anti-inflammatory activity in vivo needs to be investigated .
1.縮寫表…………………………………1
2.中文摘要………………………………3
3.英文摘要………………………………6
4.序論……………………………………8
5.實驗材料………………………………19
6.實驗方法………………………………21
7.實驗結果………………………………32
8.圖表……………………………………47
9.討論……………………………………66
10.參考文獻……………………………76
Altieri, D.C. and Edgington, T.S. (1988) A monoclonal antibody reacting with distinct adhesion molecules defines a transition in the functional state of the receptor CD11b/CD18 (Mac-1). J Immunol, 141, 2656-2660.

Arefieva, T.L. and Krasnikova, T.L. (2001) Monocytic cell adhesion to intact and plasmin-modified fibrinogen: possible involvement of Mac-1 (CD11b/CD18) and ICAM-1 (CD54). J Cell Physiol, 188, 403-409.
Babina, M. and Henz, B.M. (2003) All-trans retinoic acid down-regulates expression and function of beta2 integrins by human monocytes: opposite effects on monocytic cell lines. Eur J Immunol, 33, 616-625.
Beisiegel, U., Weber, W. and Bengtsson-Olivecrona, G. (1991) Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc Natl Acad Sci U S A, 88, 8342-8346.
Bu, G., Williams, S., Strickland, D.K. and Schwartz, A.L. (1992) Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator. Proc Natl Acad Sci U S A, 89, 7427-7431.
Calvete, J.J., Schafer, W., Soszka, T., Lu, W.Q., Cook, J.J., Jameson, B.A. and Niewiarowski, S. (1991) Identification of the disulfide bond pattern in albolabrin, an RGD-containing peptide from the venom of Trimeresurus albolabris: significance for the expression of platelet aggregation inhibitory activity. Biochemistry, 30, 5225-5229.
Cantinieaux, B., Hariga, C., Courtoy, P., Hupin, J. and Fondu, P. (1989) Staphylococcus aureus phagocytosis. A new cytofluorometric method using FITC and paraformaldehyde. J Immunol Methods, 121, 203-208.
Chang, C.C. and Lee, C.Y. (1963) Isolation Of Neurotoxins From The Venom Of Bungarus Multicinctus And Their Modes Of Neuromuscular Blocking Action. Arch Int Pharmacodyn Ther, 144, 241-257.
Chang, H.H. and Lo, S.J. (1998) Full-spreading platelets induced by the recombinant rhodostomin are via binding to integrins and correlated with FAK phosphorylation. Toxicon, 36, 1087-1099.
Chavakis, T., Athanasopoulos, A., Rhee, J.S., Orlova, V., Schmidt-Woll, T., Bierhaus, A., May, A.E., Celik, I., Nawroth, P.P. and Preissner, K.T. (2005) Angiostatin is a novel anti-inflammatory factor by inhibiting leukocyte recruitment. Blood, 105, 1036-1043.
Cheresh, D.A., Berliner, S.A., Vicente, V. and Ruggeri, Z.M. (1989) Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. Cell, 58, 945-953.
Chigaev, A., Zwartz, G., Graves, S.W., Dwyer, D.C., Tsuji, H., Foutz, T.D., Edwards, B.S., Prossnitz, E.R., Larson, R.S. and Sklar, L.A. (2003) Alpha4beta1 integrin affinity changes govern cell adhesion. J Biol Chem, 278, 38174-38182.
Coelho, A.L., De Freitas, M.S., Mariano-Oliveira, A., Oliveira-Carvalho, A.L., Zingali, R.B. and Barja-Fidalgo, C. (2001) Interaction of disintegrins with human neutrophils induces cytoskeleton reorganization, focal adhesion kinase activation, and extracellular-regulated kinase-2 nuclear translocation, interfering with the chemotactic function. Faseb J, 15, 1643-1645.
Coelho, A.L., De Freitas, M.S., Mariano-Oliveira, A., Rapozo, D.C., Pinto, L.F., Niewiarowski, S., Zingali, R.B., Marcinkiewicz, C. and Barja-Fidalgo, C. (2004) RGD- and MLD-disintegrins, jarastatin and EC3, activate integrin-mediated signaling modulating the human neutrophils chemotaxis, apoptosis and IL-8 gene expression. Exp Cell Res, 292, 371-384.
Esnouf, M.P. and Tunnah, G.W. (1967) The isolation and properties of the thrombin-like activity from Ancistrodon rhodostoma venom. Br J Haematol, 13, 581-590.
Gould, R.J., Polokoff, M.A., Friedman, P.A., Huang, T.F., Holt, J.C., Cook, J.J. and Niewiarowski, S. (1990) Disintegrins: a family of integrin inhibitory proteins from viper venoms. Proc Soc Exp Biol Med, 195, 168-171.
Harris, E.S., McIntyre, T.M., Prescott, S.M. and Zimmerman, G.A. (2000) The leukocyte integrins. J Biol Chem, 275, 23409-23412.
Hamik, A., Setiadi, H., Bu, G., McEver, R.P. and Morrissey, J.H. (1999) Down-regulation of monocyte tissue factor mediated by tissue factor pathway inhibitor and the low density lipoprotein receptor-related protein. J Biol Chem, 274, 4962-4969.
Herz, J., Hamann, U., Rogne, S., Myklebost, O., Gausepohl, H. and Stanley, K.K. (1988) Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. Embo J, 7, 4119-4127.
Hynes RO., (1992) Integrins: versatility, modulation, and signaling in cell adhesion.Cell.;69,11-25.
Huang, T.F., Wu, Y.J. and Ouyang, C. (1987) Characterization of a potent platelet aggregation inhibitor from Agkistrodon rhodostoma snake venom. Biochim Biophys Acta, 925, 248-257.
Huang, T.F., Liu, C.Z. and Yang, S.H. (1995) Aggretin, a novel platelet-aggregation inducer from snake (Calloselasma rhodostoma) venom, activates phospholipase C by acting as a glycoprotein Ia/IIa agonist. Biochem J, 309 (Pt 3), 1021-1027.
Huang, T.F. (1998) What have snakes taught us about integrins? Cell Mol Life Sci, 54, 527-540.
Huang, T.F., Liu, C.Z. and Yang, S.H. (1995) Aggretin, a novel platelet-aggregation inducer from snake (Calloselasma rhodostoma) venom, activates phospholipase C by acting as a glycoprotein Ia/IIa agonist. Biochem J, 309 (Pt 3), 1021-1027.
Huang, T.F., Wang, W.J., Teng, C.M., Liu, C.S. and Ouyang, C. (1991) Purification and characterization of an antiplatelet peptide, arietin, from Bitis arietans venom. Biochim Biophys Acta, 1074, 136-143.
Huang, T.F., Wu, Y.J. and Ouyang, C. (1987) Characterization of a potent platelet aggregation inhibitor from Agkistrodon rhodostoma snake venom. Biochim Biophys Acta, 925, 248-257.
Imhof, B.A. and Aurrand-Lions, M. (2004) Adhesion mechanisms regulating the migration of monocytes. Nat Rev Immunol, 4, 432-444.
Kopp, C.W., Steiner, S., Nasel, C., Seidinger, D., Mlekusch, I., Lang, W., Bartok, A., Ahmadi, R. and Minar, E. (2003) Abciximab reduces monocyte tissue factor in carotid angioplasty and stenting. Stroke, 34, 2560-2567.
Li, R., Xie, J., Kantor, C., Koistinen, V., Altieri, D.C., Nortamo, P. and Gahmberg, C.G. (1995) A peptide derived from the intercellular adhesion molecule-2 regulates the avidity of the leukocyte integrins CD11b/CD18 and CD11c/CD18. J Cell Biol, 129, 1143-1153.
Lishko, V.K., Yakubenko, V.P., Hertzberg, K.M., Grieninger, G. and Ugarova, T.P. (2001) The alternatively spliced alpha(E)C domain of human fibrinogen-420 is a novel ligand for leukocyte integrins alpha(M)beta(2) and alpha(X)beta(2). Blood, 98, 2448-2455.
Mazzone, A. and Ricevuti, G. (1995) Leukocyte CD11/CD18 integrins: biological and clinical relevance. Haematologica, 80, 161-175.

McLane, M.A., Marcinkiewicz, C., Vijay-Kumar, S., Wierzbicka-Patynowski, I. and Niewiarowski, S. (1998) Viper venom disintegrins and related molecules. Proc Soc Exp Biol Med, 219, 109-119.
Moestrup, S.K., Gliemann, J. and Pallesen, G. (1992) Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res, 269, 375-382.
Morita, T. (2004) C-type lectin-related proteins from snake venoms. Curr Drug Targets Cardiovasc Haematol Disord, 4, 357-373.
Nakstad, B., Haugen, T., Skjonsberg, O.H. and Lyberg, T. (1998) Expression of leukocyte integrins and tissue factor in mononuclear phagocytes. Eur Respir J, 12, 601-606.
Ouyang, C., Teng, C.M. and Huang, T.F. (1992) Characterization of snake venom components acting on blood coagulation and platelet function. Toxicon, 30, 945-966.
Peng, M., Lu, W., Beviglia, L., Niewiarowski, S. and Kirby, E.P. (1993) Echicetin: a snake venom protein that inhibits binding of von Willebrand factor and alboaggregins to platelet glycoprotein Ib. Blood, 81, 2321-2328.
Peng, M., Lu, W. and Kirby, E.P. (1991) Alboaggregin-B: a new platelet agonist that binds to platelet membrane glycoprotein Ib. Biochemistry, 30, 11529-11536.
Rogers, C., Edelman, E.R. and Simon, D.I. (1998) A mAb to the beta2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits. Proc Natl Acad Sci U S A, 95, 10134-10139.
Read, M.S., Smith, S.V., Lamb, M.A. and Brinkhous, K.M. (1989) Role of botrocetin in platelet agglutination: formation of an activated complex of botrocetin and von Willebrand factor. Blood, 74, 1031-1035.
Reyes-Reyes, M., Mora, N., Gonzalez, G. and Rosales, C. (2002) beta1 and beta2 integrins activate different signalling pathways in monocytes. Biochem J, 363, 273-280.
Rinder, H.M., Bonan, J.L., Rinder, C.S., Ault, K.A. and Smith, B.R. (1991) Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood, 78, 1760-1769.
Ruegg, C., Yilmaz, A., Bieler, G., Bamat, J., Chaubert, P. and Lejeune, F.J. (1998) Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma. Nat Med, 4, 408-414.
Ruoslahti, E. and Pierschbacher, M.D. (1987) New perspectives in cell adhesion: RGD and integrins. Science, 238, 491-497.
Schieck, A., Kobnalik, F. and Habermann, E. (1972) The prothrombin-activating principle from echis carinatus venom. I. Preparation and biochemical properties. Naunyn Schmiedebergs Arch Pharmacol, 272, 402-416.
Schiffman, S., Theodor, I. and Rapaport, S.I. (1969) Separation from Russell''s viper venom of one fraction reacting with factor X and another reacting with factor V. Biochemistry, 8, 1397-1405.
Simon, D.I., Xu, H., Ortlepp, S., Rogers, C. and Rao, N.K. (1997) 7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross-reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1. Arterioscler Thromb Vasc Biol, 17, 528-535.
Smith, J.W., Piotrowicz, R.S. and Mathis, D. (1994) A mechanism for divalent cation regulation of beta 3-integrins. J Biol Chem, 269, 960-967.
Spijkers, P.P., da Costa Martins, P., Westein, E., Gahmberg, C.G., Zwaginga, J.J. and Lenting, P.J. (2005) LDL-receptor-related protein regulates beta2-integrin-mediated leukocyte adhesion. Blood, 105, 170-177.
Sussmuth, S.D., Muscholl-Silberhorn, A., Wirth, R., Susa, M., Marre, R. and Rozdzinski, E. (2000) Aggregation substance promotes adherence, phagocytosis, and intracellular survival of Enterococcus faecalis within human macrophages and suppresses respiratory burst. Infect Immun, 68, 4900-4906.
Tamkun, J.W., DeSimone, D.W., Fonda, D., Patel, R.S., Buck, C., Horwitz, A.F. and Hynes, R.O. (1986) Structure of integrin, a glycoprotein involved in the transmembrane linkage between fibronectin and actin. Cell, 46, 271-282.
Taniguchi-Sidle, A. and Isenman, D.E. (1992) Mutagenesis of the Arg-Gly-Asp triplet in human complement component C3 does not abolish binding of iC3b to the leukocyte integrin complement receptor type III (CR3, CD11b/CD18). J Biol Chem, 267, 635-643.
Tseng, Y.L., Peng, H.C. and Huang, T.F. (2004) Rhodostomin, a disintegrin, inhibits adhesion of neutrophils to fibrinogen and attenuates superoxide production. J Biomed Sci, 11, 683-691.
Ugarova, T.P. and Yakubenko, V.P. (2001) Recognition of fibrinogen by leukocyte integrins. Ann N Y Acad Sci, 936, 368-385.
Willnow, T.E., Orth, K. and Herz, J. (1994) Molecular dissection of ligand binding sites on the low density lipoprotein receptor-related protein. J Biol Chem, 269, 15827-15832.
Wu, W.B., Peng, H.C. and Huang, T.F. (2003) Disintegrin causes proteolysis of beta-catenin and apoptosis of endothelial cells. Involvement of cell-cell and cell-ECM interactions in regulating cell viability. Exp Cell Res, 286, 115-127.
Yeh, C.H., Peng, H.C., Yih, J.B. and Huang, T.F. (1998) A new short chain RGD-containing disintegrin, accutin, inhibits the common pathway of human platelet aggregation. Biochim Biophys Acta, 1425, 493-504.
Yonekawa, K. and Harlan, J.M. (2005) Targeting leukocyte integrins in human diseases. J Leukoc Biol, 77, 129-140.
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
系統版面圖檔 系統版面圖檔